These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38099030)

  • 1. Comparative Efficacy and Safety of Super-Bioavailable Itraconazole-130 mg Once Daily in Obese and Non-Obese Patients of Glabrous Tinea.
    Shenoy M; De A; Shah B; Das A; Saraswat A; Lahiri K; Dhoot D
    Indian Dermatol Online J; 2023; 14(6):839-843. PubMed ID: 38099030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial.
    Shenoy MM; De A; Shah B; Das A; Saraswat A; Lahiri K; Yadav S; Sarda A; Chakraborty D; J D; Kamat S; Doshi Y; Gonsalves N; Choudhary A; Dhoot D; Mahadkar N; Bhushan S; Gadkari R; Barkate H
    Drug Des Devel Ther; 2023; 17():2899-2908. PubMed ID: 37766823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Efficacy of Super Bioavailable Itraconazole Capsules 50 mg vs 65 mg Twice Daily in the Management of Glabrous Tinea.
    Shah B; Mistry D; Jairam D; Kansara K; Pandya R; Vasani P; Dhoot D; Mahadkar N; Bhushan S; Barkate H
    Infect Drug Resist; 2023; 16():2409-2416. PubMed ID: 37125212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Open-Label, Randomized, Double-Arm Clinical Trial to Compare the Effectiveness and Safety of Super Bioavailable Itraconazole Capsules and Itraconazole Capsules in the Management of Dermatophytosis in India.
    Shenoy M; Dhoot D; Mahajan H; Barkate H
    Clin Cosmet Investig Dermatol; 2021; 14():1367-1376. PubMed ID: 34611418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis.
    Dhoot D; Jain GK; Manjhi M; Kesharwani P; Mahadkar N; Barkate H
    Drugs Context; 2023; 12():. PubMed ID: 36660014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Use of Super-Bioavailable Itraconazole for the Management of Dermatophytosis: Consensus Statement by Dermatologists from India via the Modified Delphi Technique.
    Saraswat A; Dogra S; Shenoy M; Verma S; K S; Ghate S; Ganjoo A; Aurangabadkar S; Tiwari A; Poojary S; Inamdar A; Majid I; Girdhar M; Shah B; Varma S; Ramamoorthy R; Dhoot D; Barkate H
    Dermatology; 2024; 240(4):671-683. PubMed ID: 38697027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of plasma levels of itraconazole with treatment response at 4 weeks in chronic dermatophytosis: Results of a randomised controlled trial.
    Bhalavi H; Shaw D; Mehta H; Narang T; Sachdeva N; Shafiq N; Rudramurthy SM; Dogra S
    Mycoses; 2023 Apr; 66(4):281-288. PubMed ID: 36457207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial.
    Singh S; Chandra U; Anchan VN; Verma P; Tilak R
    Br J Dermatol; 2020 Nov; 183(5):840-846. PubMed ID: 32538466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voriconazole is superior to combined itraconazole/isotretinoin therapy and itraconazole monotherapy in recalcitrant dermatophytosis.
    Khattab F; Elkholy BM; Taha M; Abd-Elbaset A; Fawzy M
    Mycoses; 2022 Dec; 65(12):1194-1201. PubMed ID: 35943822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of efficacy and safety of oral terbinafine and itraconazole combination therapy in the management of dermatophytosis.
    Sharma P; Bhalla M; Thami GP; Chander J
    J Dermatolog Treat; 2020 Nov; 31(7):749-753. PubMed ID: 31030594
    [No Abstract]   [Full Text] [Related]  

  • 11. The Optimal Dosing Regimen of Super Bioavailable Itraconazole in Obesity: An Experimental Rat Model Study.
    Jain GK; Chitnis KR; Singhal P; Mahadkar N; Dhoot D; Barkate H
    Cureus; 2023 Apr; 15(4):e37462. PubMed ID: 37187635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) Task Force against Recalcitrant Tinea (ITART) Consensus on the Management of Glabrous Tinea (INTACT).
    Rengasamy M; Shenoy MM; Dogra S; Asokan N; Khurana A; Poojary S; Jayaraman J; Valia AR; Sardana K; Kolalapudi S; Marfatia Y; Rao PN; Bhat RM; Kura M; Pandhi D; Barua S; Kaushal V
    Indian Dermatol Online J; 2020; 11(4):502-519. PubMed ID: 32832435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic antifungal therapy for tinea capitis in children.
    Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between the efficacy of terbinafine and itraconazole orally vs. the combination of the two drugs in treating recalcitrant dermatophytosis.
    Hassaan ZRAA; Mohamed HAK; Eldahshan RM; Elsaie ML
    Sci Rep; 2023 Nov; 13(1):19037. PubMed ID: 37923859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
    Croxtall JD; Plosker GL
    Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris: A Randomized Clinical Trial.
    Khurana A; Agarwal A; Agrawal D; Panesar S; Ghadlinge M; Sardana K; Sethia K; Malhotra S; Chauhan A; Mehta N
    JAMA Dermatol; 2022 Sep; 158(11):1269-78. PubMed ID: 36103158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse after Oral Terbinafine Therapy in Dermatophytosis: A Clinical and Mycological Study.
    Majid I; Sheikh G; Kanth F; Hakak R
    Indian J Dermatol; 2016; 61(5):529-33. PubMed ID: 27688443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of the efficacy of itraconazole with terbinafine cream versus itraconazole with sertaconazole cream in dermatophytosis: A within person pilot study.
    Baveja S; Vashisht D; Kothari R; Venugopal R; Kumar Joshi R
    Med J Armed Forces India; 2023; 79(5):526-530. PubMed ID: 37719899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Amorolfine Lotion 0.25% w/v Compared to Amorolfine Cream 0.25% w/w in Patients With Superficial Fungal Infections of the Skin: A Multi-center, Randomized, Open-Label, Active-Controlled, Non-inferiority Phase III Clinical Trial.
    Rao MKP; Siddananjappa L; Sidana N; Deshmukh A; Diwari B; Podder I; Kumar S; Mittal R; Daultani P; Jaiswal A; Chinda M
    Cureus; 2024 May; 16(5):e60162. PubMed ID: 38868264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole.
    Möhrenschlager M; Schnopp C; Fesq H; Strom K; Beham A; Mempel M; Thomsen S; Brockow K; Wessner DB; Heidelberger A; Ruhdorfer S; Weigl L; Seidl HP; Ring J; Abeck D
    Br J Dermatol; 2000 Nov; 143(5):1011-5. PubMed ID: 11069511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.